Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Janina Krell-Roesch

Showing results (71-80 of 81) with videos related to

Pageof 9
Sort By:
Journal of Alzheimer'S Disease : JAD|November 20, 2020
Physical Activity and Trajectory of Cognitive Change in Older Persons: Mayo Clinic Study of AgingJanina Krell-Roesch, Jeremy A Syrjanen, Jelena Bezold, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences|October 22, 2020
Association of Cortical and Subcortical β-Amyloid With Standardized Measures of Depressive and Anxiety Symptoms in Adults Without DementiaJanina Krell-Roesch, Jeremy A Syrjanen, Martin Rakusa, et al.
Journal of Alzheimer'S Disease Reports|November 29, 2023
Association of Cerebrovascular Imaging Biomarkers, Depression, and Anxiety, with Mild Cognitive ImpairmentMaria Vassilaki, Jeremy A Syrjanen, Janina Krell-Roesch, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|July 11, 2020
Brain Regional Glucose Metabolism, Neuropsychiatric Symptoms, and the Risk of Incident Mild Cognitive Impairment: The Mayo Clinic Study of AgingJanina Krell-Roesch, Jeremy A Syrjanen, Maria Vassilaki, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences|December 5, 2022
Mid- and Late-Life Physical Activity and Neuropsychiatric Symptoms in Dementia-Free Older Adults: Mayo Clinic Study of AgingJanina Krell-Roesch, Jeremy A Syrjanen, Jelena Bezold, et al.
Neurology|February 6, 2015
Neuropsychiatric symptoms, APOE ε4, and the risk of incident dementia: a population-based studyAnna Pink, Gorazd B Stokin, Mairead M Bartley, et al.
Journal of Alzheimer'S Disease : JAD|July 12, 2024
Prevalence of Dementia and Cognitive Impairment in East Africa Region: A Scoping Review of Population-Based Studies and Call for Further ResearchMuluken A Yenesew, Janina Krell-Roesch, Betelhem Fekadu, et al.
Neurology|December 2, 2025
Physical and Cognitive Activities and Trajectories of AD Neuroimaging Biomarkers: Longitudinal Analysis in the Mayo Clinic Study of AgingJanina Krell-Roesch, Jeremy A Syrjanen, Allison L Hansen, et al.
International Psychogeriatrics|December 5, 2017
Depressive and anxiety symptoms and cortical amyloid deposition among cognitively normal elderly persons: the Mayo Clinic Study of AgingJanina Krell-Roesch, Val J Lowe, Jennifer Neureiter, et al.
Psychiatric Research and Clinical Practice|March 13, 2023
Interactions Between Neuropsychiatric Symptoms and Alzheimer's Disease Neuroimaging Biomarkers in Predicting Longitudinal Cognitive DeclineAnna Pink, Janina Krell-Roesch, Jeremy A Syrjanen, et al.
Pageof 9

Showing results (71-80 of 81) with videos related to

Sort By:
Pageof 9
Journal of Alzheimer'S Disease : JAD|November 20, 2020
Physical Activity and Trajectory of Cognitive Change in Older Persons: Mayo Clinic Study of AgingJanina Krell-Roesch, Jeremy A Syrjanen, Jelena Bezold, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences|October 22, 2020
Association of Cortical and Subcortical β-Amyloid With Standardized Measures of Depressive and Anxiety Symptoms in Adults Without DementiaJanina Krell-Roesch, Jeremy A Syrjanen, Martin Rakusa, et al.
Journal of Alzheimer'S Disease Reports|November 29, 2023
Association of Cerebrovascular Imaging Biomarkers, Depression, and Anxiety, with Mild Cognitive ImpairmentMaria Vassilaki, Jeremy A Syrjanen, Janina Krell-Roesch, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|July 11, 2020
Brain Regional Glucose Metabolism, Neuropsychiatric Symptoms, and the Risk of Incident Mild Cognitive Impairment: The Mayo Clinic Study of AgingJanina Krell-Roesch, Jeremy A Syrjanen, Maria Vassilaki, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences|December 5, 2022
Mid- and Late-Life Physical Activity and Neuropsychiatric Symptoms in Dementia-Free Older Adults: Mayo Clinic Study of AgingJanina Krell-Roesch, Jeremy A Syrjanen, Jelena Bezold, et al.
Neurology|February 6, 2015
Neuropsychiatric symptoms, APOE ε4, and the risk of incident dementia: a population-based studyAnna Pink, Gorazd B Stokin, Mairead M Bartley, et al.
Journal of Alzheimer'S Disease : JAD|July 12, 2024
Prevalence of Dementia and Cognitive Impairment in East Africa Region: A Scoping Review of Population-Based Studies and Call for Further ResearchMuluken A Yenesew, Janina Krell-Roesch, Betelhem Fekadu, et al.
Neurology|December 2, 2025
Physical and Cognitive Activities and Trajectories of AD Neuroimaging Biomarkers: Longitudinal Analysis in the Mayo Clinic Study of AgingJanina Krell-Roesch, Jeremy A Syrjanen, Allison L Hansen, et al.
International Psychogeriatrics|December 5, 2017
Depressive and anxiety symptoms and cortical amyloid deposition among cognitively normal elderly persons: the Mayo Clinic Study of AgingJanina Krell-Roesch, Val J Lowe, Jennifer Neureiter, et al.
Psychiatric Research and Clinical Practice|March 13, 2023
Interactions Between Neuropsychiatric Symptoms and Alzheimer's Disease Neuroimaging Biomarkers in Predicting Longitudinal Cognitive DeclineAnna Pink, Janina Krell-Roesch, Jeremy A Syrjanen, et al.
Pageof 9